Author

AeSoon L. Bensen

Oregon Health & Science UniversityORCID 0000-0003-4421-8370Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Ben EmeryiD· 1 shared DENNIS N. BOURDETTEiD· 1 shared E. Calkins· 1 shared Edvinas PociusiD· 1 shared Gail MarracciiD· 1 shared James E. KorkolaiD· 1 shared Jane ArterberryiD· 1 shared Mark A. DaneiD· 1 shared

Activity by Year

2020-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Ben EmeryORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJul 15, 2025

S-Nitrosylated COX-2 is a TME-regulated breast cancer biomarker of mesenchymal phenotypes

Reuben J. Hoffmann, AeSoon L. Bensen, Mark A. Dane…·Pepper S. Schedin

This study identifies SNO-COX-2 as a biomarker for mesenchymal phenotypes in breast cancer, showing its microenvironmental regulation and association with invasive growth.

DOI 10.1101/2025.07.15.664474

humanmouse

𝕏 PostBluesky

NeuroscienceJournal of NeuroimmunologyPeer-reviewedDec 27, 2020

Thyroid hormone and thyromimetics inhibit myelin and axonal degeneration and oligodendrocyte loss in EAE

Priya Chaudhary, Gail Marracci, E. Calkins…·DENNIS N. BOURDETTE

This study shows that thyroid hormone and thyromimetics reduce disease severity and protect oligodendrocytes in EAE by decreasing myelin and axonal degeneration.

38 citations

mouseexperimental assay

𝕏 PostBluesky